|
The affected pk papyrus stent systems were not returned to biotronik and could therefore not be subjected to a technical investigation.Images of the case such as angiographies could also not be obtained.The provided clinical information (pk papyrus device registration form, cathlab report) and the product release documentation were reviewed to establish whether a device deficiency contributed to this event.Review of the product release documentation confirmed that the devices were manufactured according to specifications and fulfilled all the requirements of in-process and final inspection.Based on the provided documentation and the conducted review no manufacturing related root cause could be identified.The treating physician rated the occurrence as both no device- and no procedure-related complication.Pk papyrus is indicated for the treatment of acute perforations of native coronary arteries and coronary bypass grafts in vessels 2.5 to 5.0 mm in diameter.As such, this device is typically used in emergent response to a life-threatening adverse procedural event unrelated to use of the pk papyrus.
|
|
The intention was to treat a lesion in the proximal lcx by rotablation during which a coronary artery perforation type iii occurred.To stop the bleeding balloon dilation was performed.A pk papyrus us 3.0/20 was introduced into the patients body and inflated with 8 atm.However, the perforation was not sealed successfully (reported separately).Therefore, both a drug eluting stent and the complaint pk papyrus us 4.0/15 were implanted, but still the perforation could not be sealed, despite post-dilation with two balloons.Thereafter, the patient underwent an emergent cabg and passed away due to hemorrhagic shock.
|